Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Substance Abuse
Trial Information
A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse/Dependence
Are you experiencing problems as a result of drinking too much?
Do you want to cut back on your drinking, but have trouble stopping on your own? Are you also feeling sad, blue, or down in the dumps?
Massachusetts General Hospital is conducting a research study for people between the ages of 21 and 64 who are feeling depressed and want to cut down on their drinking. The study offers participants office visits, medical exams, study medication, and behavioral treatment at no cost.
For more information, please contact Soo at 617-724-2936 or syoun@partners.org
Soo Jeong Youn
Depression Clinical and Research Program
50 Staniford Street
Suit 401
Boston, MA 02114
Phone: 617-724-2936
EMail: syoun@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.